SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-059757
Filing Date
2024-05-14
Accepted
2024-05-14 17:01:36
Documents
57
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bcab-20240331.htm   iXBRL 10-Q 1370746
2 EX-10.1 bcab-ex10_1.htm EX-10.1 164001
3 EX-10.2 bcab-ex10_2.htm EX-10.2 44292
4 EX-31.1 bcab-ex31_1.htm EX-31.1 15228
5 EX-31.2 bcab-ex31_2.htm EX-31.2 15180
6 EX-32.1 bcab-ex32_1.htm EX-32.1 13956
  Complete submission text file 0000950170-24-059757.txt   5532181

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bcab-20240331.xsd EX-101.SCH 896032
61 EXTRACTED XBRL INSTANCE DOCUMENT bcab-20240331_htm.xml XML 652913
Mailing Address 11085 TORREYANA ROAD SAN DIEGO CA 92121
Business Address 11085 TORREYANA ROAD SAN DIEGO CA 92121 858-558-0708
BioAtla, Inc. (Filer) CIK: 0001826892 (see all company filings)

IRS No.: 851922320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39787 | Film No.: 24945515
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)